Shenzhen Salubris Pharmaceuticals (002294.SZ) Earnings Analysis
Shenzhen Salubris Pharmaceuticals (002294.SZ) next reports earnings on 2026-08-25. Last quarter (2026-04-21) it missed with EPS 0.0635 CNY vs 0.18 CNY est (-64.7%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E 57.93.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 002294.SZ next report earnings?
| Next earnings date | 2026-08-25 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
002294.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-21 | 0.0635 CNY | 0.18 CNY | -64.7% | Miss |
| 2026-04-20 | 0.2 CNY | n/a | n/a | n/a |
| 2025-10-27 | 0.1934 CNY | 0.12 CNY | +61.2% | Beat |
| 2025-08-19 | 0.1478 CNY | 0.02233 CNY | +561.9% | Beat |
| 2025-04-21 | 0.18 CNY | 0.18 CNY | 0% | Beat |
| 2024-10-21 | 0.15 CNY | 0.13 CNY | +15.4% | Beat |
| 2024-08-26 | 0.13 CNY | 0.16 CNY | -18.8% | Miss |
Beat rate: 4/6 (67%) over reported quarters with consensus data.
002294.SZ valuation and analyst view
| Trailing P/E | 57.93 |
|---|---|
| Trailing EPS | 0.60678 CNY |
| Price / book | 4.26 |
| Dividend yield | 1.57% |
| Market cap | 38.36B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Shenzhen Salubris Pharmaceuticals (002294.SZ)'s next earnings date?
Shenzhen Salubris Pharmaceuticals is next scheduled to report on 2026-08-25.
Did 002294.SZ beat earnings last quarter?
In its 2026-04-21 report, 002294.SZ posted EPS of 0.0635 CNY versus a 0.18 CNY estimate — a miss of 64.7%.
What is 002294.SZ's earnings track record?
Over the last 6 reported quarters with consensus data, 002294.SZ beat estimates 4 times (67%).
What is 002294.SZ's current P/E ratio and EPS?
002294.SZ trades at a trailing P/E of 57.93 on trailing EPS of 0.6067791674797862 CNY.
What do analysts rate 002294.SZ?
002294.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.